February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3 – Oncology Brothers
Feb 14, 2024, 18:13

Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3 – Oncology Brothers

Oncology Brothers made the following post on X:

“Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3: NALIRIFOX vs. Gem/Abrax

  • mOS 11.1mos Vs 9.2mos (HR: 0.83)
  • Cross trial comparison, similar OS w/ FOLFIRINIOX
  • Save liposomal for later lines?”

Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3 - Oncology Brothers

Source: Oncology Brothers/X